scholarly article | Q13442814 |
P50 | author | Byung-Hee Oh | Q41652919 |
Joo-Yong Hahn | Q87032332 | ||
Jang Whan Bae | Q88293693 | ||
Kyung Woo Park | Q89316500 | ||
Chan Soo Shin | Q90972086 | ||
Young-Bae Park | Q116485843 | ||
Yun-Shik Choi | Q117234752 | ||
P2093 | author name string | Kwang-Il Kim | |
Hyo-Soo Kim | |||
Hyun-Ju Cho | |||
In-Ho Chae | |||
Bon-Kown Koo | |||
Hyung-Sun Yuk | |||
P2860 | cites work | Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers | Q22008565 |
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling | Q28198809 | ||
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo | Q28511213 | ||
Wnt signaling: a common theme in animal development | Q29547527 | ||
IAP proteins: blocking the road to death's door | Q29619844 | ||
Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus | Q29620188 | ||
RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload | Q33857945 | ||
Evidence that human cardiac myocytes divide after myocardial infarction | Q33950386 | ||
Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction | Q34161036 | ||
Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes | Q35753280 | ||
An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control | Q36065506 | ||
Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts | Q38347568 | ||
Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin | Q38783903 | ||
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion | Q40350049 | ||
Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. | Q40468189 | ||
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin | Q40518725 | ||
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation | Q40522774 | ||
Constitutively active glycogen synthase kinase-3beta gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats | Q40581567 | ||
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. | Q40767544 | ||
Signal transduction of beta-catenin | Q40952528 | ||
Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation | Q42472178 | ||
Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction | Q43010441 | ||
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective | Q43909380 | ||
Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage | Q44488016 | ||
Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium | Q46804424 | ||
Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. | Q47438866 | ||
Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. | Q52564453 | ||
Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. | Q53611030 | ||
Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase. | Q53624209 | ||
Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. | Q53635273 | ||
Survivin and molecular pathogenesis of colorectal cancer. | Q53922433 | ||
P433 | issue | 41 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P1104 | number of pages | 11 | |
P304 | page(s) | 30979-30989 | |
P577 | publication date | 2006-08-18 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts | |
P478 | volume | 281 |
Q34044380 | Active Wnt signaling in response to cardiac injury |
Q92405378 | Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma |
Q89972356 | Ageing-related changes in the levels of β-catenin, CacyBP/SIP, galectin-3 and immunoproteasome subunit LMP7 in the heart of men |
Q36072394 | Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway |
Q92883408 | Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories |
Q37330565 | Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. |
Q93348694 | Comparative evaluation of CacyBP/SIP protein, β-catenin, and immunoproteasome subunit LMP7 in the heart of rats with hypertension of different etiology |
Q39485853 | Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells |
Q35660775 | Differential effects of Akt1 signaling on short- versus long-term consequences of myocardial infarction and reperfusion injury |
Q59136742 | Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury |
Q38814061 | Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway |
Q38541546 | Electrical stimulation to optimize cardioprotective exosomes from cardiac stem cells. |
Q92996743 | Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance |
Q56027585 | Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: Role of β-catenin transduction and cell dose |
Q42775592 | Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition |
Q37716851 | Fibroblasts in myocardial infarction: a role in inflammation and repair |
Q37090676 | Fibrosis of the Neonatal Mouse Heart After Cryoinjury Is Accompanied by Wnt Signaling Activation and Epicardial-to-Mesenchymal Transition |
Q36209853 | GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway |
Q64988590 | GSK3β inhibition and canonical Wnt signaling in mice hearts after myocardial ischemic damage. |
Q40802294 | Gene transfer to promote cardiac regeneration |
Q37998444 | Importance of myocyte-nonmyocyte interactions in cardiac development and disease |
Q36819462 | Inhibition of Wnt6 by Sfrp2 regulates adult cardiac progenitor cell differentiation by differential modulation of Wnt pathways |
Q38042490 | Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing |
Q92984589 | Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension |
Q42176692 | Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice |
Q39859295 | Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy. |
Q43066362 | M-cadherin-inhibited phosphorylation of ß-catenin augments differentiation of mouse myoblasts |
Q40564767 | Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. |
Q35424798 | Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury |
Q51561512 | MiR-154 directly suppresses DKK2 to activate Wnt signaling pathway and enhance activation of cardiac fibroblasts. |
Q28297656 | Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases |
Q35665230 | N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction |
Q92184939 | Progranulin deficiency leads to enhanced age-related cardiac hypertrophy through complement C1q-induced β-catenin activation |
Q40061408 | Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells |
Q54381911 | Reverse remodelling and recovery from heart failure are associated with complex patterns of gene expression. |
Q38064702 | Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. |
Q30524835 | Secondary sphere formation enhances the functionality of cardiac progenitor cells |
Q97428034 | Secreted frizzled-related protein 2 prevents pressure-overload-induced cardiac hypertrophy by targeting the Wnt/β-catenin pathway |
Q37636881 | Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis |
Q89427974 | Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct |
Q38452473 | The (dys)functional extracellular matrix |
Q37882050 | The Wnt/Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand? |
Q47787830 | The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling. |
Q37331189 | Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure. |
Q47299786 | WNT Signaling in Cardiac and Vascular Disease. |
Q38542451 | Wnt Signaling in Cardiac Disease |
Q52815224 | Wnt Signaling in Cardiac Remodeling and Heart Failure. |
Q38874087 | Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration |
Q36144944 | Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis. |
Q28573942 | miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activity |
Search more.